The most useful investigation for identifying the fistulae is a barium enema with air contrast 8 ,9. It may also be demonstrated by barium meal. However, Hux and Zuska'' found that whereas 100% of duodenocolic fistulae could be identified by barium enema, only 50% were seen following a barium meal. This is thought to be due to the higher colonic intraluminal pressure allowing contrast to enter the relatively narrow and non-distensible fistulous tract. Barium enema could precisely locate 75% of duodenocolic fistulae 9 .
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Surgery for malignant duodenocolic fistulae is complicated by the fact that the tumours are frequently at an advanced stage and, therefore, the resectability rate is low. The complex nutritional and electrolyte disturhances, the extent of tumour spread, and the patient's general medical state preclude a uniform surgical approach. Earlier authors recommended preliminary surgery to bypass the fistula either by gastrojejunostomy or ilcotransversc colostorny". Definitive surgery usually involves right hemicolectomy and local removal of the involved duodenal wall, in view of the predominance of right colonic lesions.
It has been argued that local excision is usually inadequate and that radical treatments including pancreatoduodenectomy, and even gastrectomy may offerthe greatest chance of cure 10, 11. Unfortunately, the prognosis for these patients is usually measured in months although a 26-year survival foliowiTlg a two stage resection of a malignant duodenocolic fistula originating in the transverse colon has been reported".
INTRODUCTION
Primary non-carcinoid adenocarcinoma of the appendix is rare and since the first description in 1882 less than 300 cases have been reported world wide '. The natural history and appropriate management of the condition arc therefore not widely understood. The case presented below bears many typical features and provides illustration for a review of the treatment of this malignancy.
CASE HISTORY
A 74-year-old man presented with a 2-day history of right iliac fossa pain and associated nausea, vomiting, and diarrhoea. Six years previously he had undergone an anterior resection of the rectum for a Dukes A carcinoma. Barium enema examination 9 months prior to this presentation was normal, at which point he had been discharged from follow up. Clinical examination revealed right iliac fossa peri ton ism together with a temperature of 37.4°C and tachycardia of 100 beats/min. A leucocytosis of 11 4-00 was noted whilst chest and abdominal radiographs were normal.
The patient proceeded to surgery with a working diagnosis of acute appendicitis, and an acutely inflamed nonperforated appendix was removed. Subsequent histological examination of the resected specimen revealed a focus of moderately differentiated adenocarcinoma of colonic type in the distal appendix (see Figure 1 ) penetrating through to the serosa but not involving the stump. On the basis of the above findings, the patient was submitted to full 
DISCUSSION
Primary non-carcinoid adenocarcinoma of the appendix is rare, accounting for less than 0.5% of all gastrointestinal tract malignancies/. The peak incidence is in the sixth decade and there is a slight male predominance. Histological classification is into either mucinous (55%), colonic (34%), or adenocarcinoid types (11 %) the latter exhibiting mixed cell lines 1 • The vast majority of affected patients present with acute appendicitis, probably due to early malignant obstruction of the appendiceal lumen leading to superimposed infection. Smaller numbers of cases present with an abdominal mass whilst pseudomyxoma peritonei may be the presenting feature of mucinous adenocarcinoma.'. The diagnosis is seldom if ever entertained preoperatively, with the possibility of carcinoma usually only being considered by the histopathologist. The overall prognosis of primary adenocarcinoma of the appendix varies from 30~55% depending on the pathological staging and the histological type and grade of the lesion 1,4.
Lymph node metastases are present at diagnosis in up to 45% of patients with colonic-type or adenocarcinoid turnoursl-i, Early dissemination from seemingly localized lesions may be the result of an early tendency to perforation, again due to luminal obstruction by the tumour and to a deficiency of circular and longitudinal muscle layers which may be apparent in some areas of the appendiceal wall". In contrast, mucinous adenocarcinoma does not exhibit haematogenous or lymphatic spread and is associated with a more favourable prognosis, even in the presence of widespread intraperitoneal disease 3 . The incidence of synchronous and metachronous tumours at 38% is higher than expected in colonic carcinoma and approximately half of these lesions occur outside the gastrointestinal tract l ) ,7.
Traditional surgical teaching has advocated simple appendicectomy for those lesions which appear grossly localizcds-", However, a number of recent studies have demonstrated a clear survival benefit of approximately 50% at 5 years, for those patients subjected to right hemicolectomy rather than simple appendicectomy ' , 4, 7, 10, II. This benefit is evident for mucinous as well as colonic and adcnocarcinoid variants. Such a radical approach requires rcexploration of the abdomen in almost all cases, but leads to an upstaging of the disease in as many as 38% of patients, due to the detection of hitherto unsuspected metastases 1.
Adjuvant chemotherapy should be prescribed according to guidelines established for colonic cancer 12.
In summary the diagnosis of adenocarcinoma, whilst unusual, should at least be considered in those patients over 40 years of age presenting with acute appendicitis, particularly if there is any suggestion of a mass within the appendix. Once diagnosed, all but the frailest of patients are best managed by right hemicolectomy. The increased likelihood of synchronous tumours and subsequent metachronous lesions must be borne in mind, and we commend preoperative colonoscopic screening in all patients followed by lifelong surveillance. (Accepted 3I August 1995) HISTORY A 8.4-year-old girl was initially treated for acute myeloid leukaemia (AML) with standard chemotherapy and allogenic BMT conditions with cyclophosphamide (60mg/kg/day on 2 consecutive days) and 10 Gy single fraction TBI. Eighteen months after TBI, an initial endocrine assessment revealed an exaggerated TSH response to intravenous TRH, with normal thyroid function, and a borderline GH response (GH peak value 18mUll) to a 'primed' insulin tolerance test. At 12 years there was spontaneous onset of breast development and menarche occurred one year later. Her pattern of growth was suboptimal, GH treatment was commenced and a final height of 154.8 ems was attained which was in the lower range of her genetic target (152.7-170.5 em). Her periods were regular over the first 3 years but at 16 years she presented with secondary amennorhoea. At that time she was overweight (body mass index: 26 kg/m 2 ) . Basal gonadotrophin values were not raised with no abnormalities in the LH/FSH ratio, oestrogen levels were low and neither ovarian cystic activity nor polycystic ovaries were demonstrated on pelvic ultrasound imaging. Oestrogen/progesterone replacement treatment was recommended but was not complied with. Thirty months later, she was also found to be hypertensive (blood pressure 14D systolic, 100 diastolic, mmHg) in addition to secondary amenorrhoea and within 3 months developed progressive virilization with hirsutism and acne. Hyperandrogenism, with elevated testosterone (4.5 nmolll, adult female range 0.8-3.0) androstenedione (13.8 nmolll, normal range 2-10) and DHEAS (12.8 nmolll, normal range 2.7-8.7) values were biochemically confirmed. Oestradiol levels were below 250 pmolll on several different occasions. Pulsatile gonadotrophin secretion was abnormal for the patient's stage of sexual maturation (Figure 1 ). Pelvic imaging studies showed an enhancing, partly calcified,mass (3 X 5 X 5 em) in the right side of the pelvis. At laparatomy both ovaries were removed and a sclerosing stromal tumour was found in the right ovary. The left
